5 best CRISPR stocks to buy 5 best CRISPR stocks to buy Not every investor will want to buy CRISPR gene-editing stocks. These stocks tend to be highly risky and volatile. However, for aggressive ...

In a report released yesterday, Terence Flynn from Morgan Stanley maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report), ...

Qiagen NV (NYSE:QGEN) recently enhanced its product offerings with the introduction of the QIAprep&amp CRISPR Kit and CRISPR Q-Primer ... QGEN) with a Buy rating and a price target of $54.

Qiagen NV (NYSE:QGEN) recently enhanced its product offerings with the introduction of the QIAprep& CRISPR Kit and CRISPR Q-Primer ... QGEN) with a Buy rating and a price target of $54.

CRISPR Therapeutics AG (CRSP) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

In a report released yesterday, Alec Stranahan from Bank of America Securities maintained a Buy rating on Crispr Therapeutics AG (CRSP – ...

In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $41.21, denoting a -1.44% change from the preceding trading day. ZUG, Switzerland and BOSTON, Jan. 29, 2025 (GLOBE ...